Skyla (levonorgestrel-releasing intrauterine system)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
WARNINGS AND PRECAUTIONS
Breast Cancer
Observational studies of the risk of breast cancer with use of a LNG-releasing...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Mirena | Study | Warnings